当前位置：首页 > 文献互助 > 互助详情

期刊论文Correction to Lancet Diabetes Endocrinol 2021; 9: 743–54复制

飞天小兔神 1个月前 70 已完结

1. 系统已在2026-06-09 14:40:41对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/S2213-8587(22)00223-6复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858722002236复制

其他信息:

出版社: Elsevier BV

上一篇：Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

下一篇：Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials

互助时间线

2026-06-07 09:08:49 [完结求助]

系统完结了求助, 已自动确认了文学探索应助的文件是正确的, 求助状态变成已完结

2026-06-02 14:40:41 [上传文件]

文学探索上传了文件(pdf 85.41 KB), 求助状态变成待确认

2026-06-02 09:08:49 [发起求助]

最新发布的求助

Long-term safety and efficacy of intracortical microstimulation in humans 3分钟前

等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 20分钟前

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 32分钟前

Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 37分钟前

Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 38分钟前

Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 47分钟前

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 53分钟前

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 56分钟前

Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前

Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前

Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction … 1小时前

Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis 1小时前